Koninklijke Philips NV - Asset Resilience Ratio
Koninklijke Philips NV (PHIA) has an Asset Resilience Ratio of 0.01% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PHIA working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2024)
This chart shows how Koninklijke Philips NV's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see PHIA asset base.
Liquid Assets Composition Over Time
This chart breaks down Koninklijke Philips NV's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore PHIA long-term investments to assets to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €2.00 Million | 0.01% |
| Total Liquid Assets | €2.00 Million | 0.01% |
Asset Resilience Insights
- Limited Liquidity: Koninklijke Philips NV maintains only 0.01% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Koninklijke Philips NV Industry Peers by Asset Resilience Ratio
Compare Koninklijke Philips NV's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
TransMedics Group Inc
NASDAQ:TMDX |
Medical Devices | 0.00% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581 |
Medical Devices | 18.80% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
Nanjing Medlander Medical Technology Co. Ltd. A
SHG:688273 |
Medical Devices | 34.29% |
Annual Asset Resilience Ratio for Koninklijke Philips NV (1999–2024)
The table below shows the annual Asset Resilience Ratio data for Koninklijke Philips NV.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.01% | €2.00 Million ≈ $2.34 Million |
€28.98 Billion ≈ $33.88 Billion |
0.00pp |
| 2023-12-31 | 0.01% | €3.00 Million ≈ $3.51 Million |
€29.41 Billion ≈ $34.38 Billion |
-0.03pp |
| 2022-12-31 | 0.04% | €11.00 Million ≈ $12.86 Million |
€30.69 Billion ≈ $35.88 Billion |
+0.03pp |
| 2021-12-31 | 0.01% | €2.00 Million ≈ $2.34 Million |
€30.96 Billion ≈ $36.20 Billion |
-- |
| 2020-12-31 | 0.00% | €0.00 ≈ $0.00 |
€27.71 Billion ≈ $32.40 Billion |
-- |
| 2019-12-31 | 0.00% | €1.00 Million ≈ $1.17 Million |
€26.98 Billion ≈ $31.55 Billion |
-1.67pp |
| 2018-12-31 | 1.68% | €436.00 Million ≈ $509.73 Million |
€26.02 Billion ≈ $30.42 Billion |
+1.67pp |
| 2017-12-31 | 0.01% | €2.00 Million ≈ $2.34 Million |
€25.32 Billion ≈ $29.60 Billion |
-0.30pp |
| 2016-12-31 | 0.31% | €101.00 Million ≈ $118.08 Million |
€32.30 Billion ≈ $37.77 Billion |
+0.27pp |
| 2015-12-31 | 0.04% | €12.00 Million ≈ $14.03 Million |
€30.98 Billion ≈ $36.21 Billion |
-0.40pp |
| 2014-12-31 | 0.44% | €125.00 Million ≈ $146.14 Million |
€28.35 Billion ≈ $33.15 Billion |
+0.40pp |
| 2013-12-31 | 0.04% | €10.00 Million ≈ $11.69 Million |
€26.56 Billion ≈ $31.05 Billion |
-0.30pp |
| 2001-12-31 | 0.34% | €130.37 Million ≈ $152.42 Million |
€38.52 Billion ≈ $45.03 Billion |
+0.05pp |
| 2000-12-31 | 0.29% | €111.80 Million ≈ $130.70 Million |
€38.65 Billion ≈ $45.18 Billion |
-4.87pp |
| 1999-12-31 | 5.16% | €1.53 Billion ≈ $1.79 Billion |
€29.58 Billion ≈ $34.58 Billion |
-- |
About Koninklijke Philips NV
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral… Read more